Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after ssri treatment in the STAR*D trial

Depression and Anxiety

Volumn 31, Issue 8, 2014, Pages 707-716

  IsHak, Waguih William ^a   Mirocha, James ^a   Christensen, Scott ^a   Wu, Fan ^b   Kwock, Richard ^b   Behjat, Joseph ^a   Pi, Sarah ^a   Akopyan, Araks ^a   Peselow, Eric D ^c   Cohen, Robert M ^d   Elashoff, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; anxiety anxiety disorders; depression; panic attacks agoraphobia; quality of life

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PANIC; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SELF REPORT; SOCIAL PHOBIA; TREATMENT OUTCOME; ADOLESCENT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; MULTICENTER STUDY; PANIC DISORDER; PATHOPHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CITALOPRAM; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84905436679     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22152     Document Type: Article

References (40)

1. Murray CJ, Lopez AD,. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
2. IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry 2011; 19 (5): 229-239.
3. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG,. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996; 169: 17-30.
4. Hansson L,. Quality of life in depression and anxiety. Int Rev Psychiatry 2002; 14 (3): 185-189.
5. Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Byrne PP, Walters EE,. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 1998; 55 (9): 801-808.
6. Reich J, Warshaw M, Peterson LG, et al. Comorbidity of panic and major depressive disorder. J Psychiatr Res 1993; 1: 23-33.
7. Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC,. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000; 176: 229-235.
8. IsHak WW, Balayan K, Bresee C, et al. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res 2013; 22 (3): 585-596.
9. Weissman MM,. Panic disorder: impact on quality of life. J Clin Psychiatry 1991; 52: 6-8.
10. Davidoff J, Christensen S, Khalili DN, Nguyen J, IsHak WW,. Quality of life in panic disorder: looking beyond symptom remission. Qual Life Res 2012; 21 (6): 945-959.
11. Vasile RG, Goldenberg I, Reich J, Goisman RM, Lavori PW, Keller MB,. Panic disorder versus panic disorder with major depression; defining and understanding differences in psychiatric morbidity. Depress Anxiety 1997; 5 (1): 12-20.
12. World Health Organization (WHO). International Classification of Functioning, Disability and Health; 2001. Available at: http://www.who.int/ classifications/icf/en/.
13. World Health Organization Quality of Life Group. Measuring Quality of Life; 1997. Available at: http://www.who.int/mental health/media/68.pdf.
14. IsHak WW, Greenberg JM, Saah T, et al. Development and validation of the individual burden of illness index for major depressive disorder (IBI-D). Adm Policy Ment Health 2013; 40 (2): 76-86.
15. Barrera TL, Norton PJ,. Quality of life impairment in generalized anxiety disorder, social phobia and panic disorder. J Anxiety Disord 2009; 23: 1086-1090.
16. Mittal D, Fortney J, Pyne J, Edlund M, Wetherell J,. Impact of comorbid anxiety disorders on health-related quality of life among patients with major depressive disorder. Psychiatry 2006; 57: 1731-7.
17. DeVeaugh-Geiss AM, West SL, Miller WC, Sleath B, Kroenke K, Gaynes BN,. Depression and comorbid panic in primary care patients. J Affect Disord 2010; 123 (1-3): 283-90.
18. Hegel MT, Unutzer J, Tang L,. Impact of comorbid panic and posttraumatic stress disorder on outcome of collaborative care for late-life depression in primary care. Am J Geriatr Psychiatry 2005; 13 (1): 48-58.
19. Rush AJ, Fava M, Wisniewski SR, et al. STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004; 25 (1): 119-142.
20. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003; 26: 457-494.
21. Endicott J, Nee J, Harrison W, Blumenthal R,. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 1993; 29 (2): 321-326.
22. Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone JRN, Osher FC,. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care 2000; 38 (11): 1141-1150.
23. Mundt JC, Marks IM, Shear MK, Greist JH,. The work and social adjustment scale: A simple measure of impairment in functioning. Br J Psychiatry 2002; 180: 461-464.
24. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item quick inventory of depressive (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54 (5): 585.
25. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
26. Montgomery SA, Asberg M,. Montgomery Asberg depression rating scale. Br J Psychiat 1979; 134: 382-389.
27. Beck A, Steer R, Brown G,. BDI-II: Beck Depression Inventory Manual. 2nd ed. San Antonio: Harcourt Brace and Company; 1969.
28. Cohen J,. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates, Inc.; 1988: 279-280.
29. Kraemer HC, Frank E, Kupfer DJ,. How to assess the clinical impact of treatments on patients, rather than the statistical impact of treatments on measures. Int J Methods Psychiatr Res 2011; 20 (2): 63-72.
30. Citrome L,. The tyranny of the P-value: effect size matters. Bull Clin Psychopharmacol 2011; 21 (2): 91-92.
31. Watson HJ, Swan A, Nathan PR,. Psychiatric diagnosis and quality of life: the additional burden of psychiatric comorbidity. Compr Psychiatry 2011; 52 (3): 265-272.
32. Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P,. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996; 53: 889-895.
33. Benvenuti A, Rucci P, Calugi S, Cassano GB, Miniati M, Frank E,. Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression. Int Clin Psychopharmacol 2010; 25 (2): 68-74.
34. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163 (11): 1905-1917.
35. Olfson M, Fireman B, Weissman MM, et al. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry 1997; 154: 1734-1740.
36. Brown C, Schulberg HC, Madonia MJ, Shear KM, Houck PR,. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996; 153: 1293-1300.
37. Lepine JP, Chignon JM, Teherani M,. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry 1993; 50: 144-149.
38. Hirschfeld RM,. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001; 3 (6): 244-254.
39. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004; 34 (7): 1299-308.
40. Cohen RM, Greenberg J, IsHak WW,. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D) to measure treatment impact and recovery in Major Depressive Disorder. JAMA Psychiatry 2013; 70 (3): 343-50.